ArticleEnvironment & health (Washington, D.C.)2026
Machine Learning Models for High-Throughput Screening of Obesogens Based on Pathway Network.
Article in Environment & health (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Tutorial on Best Practices and Pitfalls in Applying Machine Learning to Environmental Research.ACS environmental Au · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolism-disrupting chemicals increase the incidence of obesity through diverse signaling pathways. It is critical to prioritize potential obesogenic factors and systematically profile their modes of action. Here, based on adverse outcome pathway networks (AONs), we established a machine learning screening system that integrated three adverse outcome pathways (AOPs) to describe the mechanisms of chemical-induced obesity for thousands of chemicals. Notably, optimal AON-informed machine learning models achieved an accuracy above 0.95 and identified amide, aromatic/polycyclic, and nitrogen-containing structures as obesity-related. In addition, polycyclic aromatic hydrocarbons were identified as prime candidate obesogens, inducing metabolic syndrome by interfering with all three signaling pathways across the AONs. Representative obesogens predicted in this study, such as antibiotics, insecticide metabolites, and exogenous chemical glucagon, were found to predominantly target membrane, mitochondrial, and nuclear receptor signaling pathways, respectively. Furthermore, top-prioritized chemicals (such as phenanthrene, azithromycin, 1,8,9-trihydroxyanthracene, etc.) according to ranking scores were randomly selected for experimental verification, and all selected candidates exhibited pathway interference in activating specific molecular initiating events (MIEs), demonstrating the predictive model's accuracy. The developed high-throughput screening strategy can efficiently evaluate the potential obesogenic effects of emerging chemicals and provide guidance for the safe design of new chemicals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.